Laura studied Pharmacy at Universidad Complutense from Madrid, where she graduated in 2017. In the same year, she started a MSc in Biopharmaceuticals at King’s College London. After graduation, Laura joined Professor Thurston’s drug discovery laboratory. Later on, she joined AstraZeneca, Cambridge, UK; where she was part of the Advanced Drug Delivery team and worked as a pharmaceutical scientist in formulation development for small molecules and PROTACs. In November 2020, she started her PhD at DIVERSA, a start up company from Dr. María de la Fuente's group, based in Santiago de Compostela. Her work aims to develop a delivery platform for mRNA and nucleic acids using DIVERSA's proprietary technology. As part of her PhD, she was granted 'Doctorados Industriales Grant' from the Spanish Ministry of Science and Innovation, and with a European COST Action Internship at University of Copenhagen, where she compared different nanoparticle formulation methodologies. At de Lázaro Lab in NYU, Laura is comparing different mRNA nanomedicines for regenerative medicine applications.